Sygnature Discovery
Sygnature Discovery is a leading UK-based provider of integrated drug
discovery services. Sygnature employs over 50 laboratory-based medicinal
chemists and in vitro biologists in its modern, purpose-built facility in
BioCity Nottingham.
Most of these scientists have PhDs and many have 10-22 years drug
discovery experience with companies such as AstraZeneca, Pfizer, Merck and
OSI Pharmaceuticals.
Sygnature’s industry-experienced team adds considerable value to clients’
discovery programmes by undertaking complete drug discovery projects and key
elements of the drug discovery process, such as hit finding, hit-to-lead and
lead optimisation.
Sygnature’s scientists also provide significant intellectual input into
clients’ projects; thereby generating novel intellectual property. Key areas
of expertise include medicinal and computational chemistry, bioscience and
ADME/toxicity (through a strategic alliance with Cyprotex Discovery).
For more information, go to:
www.sygnaturediscovery.com
|